Cilostazol, a Phosphodiesterase 3 Inhibitor, Moderately Attenuates Behaviors Depending on Sex in the Ts65Dn Mouse Model of Down Syndrome

Overview of attention for article published in Frontiers in Aging Neuroscience, April 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

news: 1 news outlet

twitter: 4 X users

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 31 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 83,318 followers.

Cilostazol, a Phosphodiesterase 3 Inhibitor, Moderately Attenuates Behaviors Depending on Sex in the Ts65Dn Mouse Model of Down Syndrome https://t.co/8YWw3npfTh https://t.co/XQimUyXgtr

08 May 2020

Reply Repost Favourite

Cilostazol, a Phosphodiesterase 3 Inhibitor, Moderately Attenuates Behaviors Depending on Sex in the Ts65Dn Mouse Model of Down Syndrome. https://t.co/56CL9ybkhT

07 May 2020

Reply Repost Favourite

RT @FrontNeurosci: New Research: Cilostazol, a Phosphodiesterase 3 Inhibitor, Moderately Attenuates Behaviors Depending on Sex in the Ts65D…

02 May 2020

Reply Repost Favourite

New Research: Cilostazol, a Phosphodiesterase 3 Inhibitor, Moderately Attenuates Behaviors Depending on Sex in the Ts65Dn Mouse Model of Down Syndrome: People with Down syndrome, which is a trisomy of chromosome 21, exhibit… https://t.co/zTUL1DFRYh #ageing

01 May 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.